Company / Interest Expense
Chemed Corp. Interest Expense History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Interest Expense
$1.8M
FY2025
5-year range
$1.8M / $4.6M
FY2021-FY2025
Trend
-1.7%
vs FY2024
Sector context
#38 of 40
Health Care
What the data says
Among 40 Health Care companies, Chemed Corp. is in the top 5% for interest expense. Interest Expense has declined for 3 consecutive years, from $5M in FY2022 to $2M in FY2025.
Based on SEC 10-K filings.
$2M in FY2025 with a 5-year CAGR of -5.8%.
Improved from $3M to $2M over the past 2 years.
Health Care sector context is included.
Interest Expense over time
Growth rates
- 3-Year CAGR
- -27.5%
- 5-Year CAGR
- -5.8%
- 10-Year CAGR
- -
Sector benchmark
Top 5% in Health CareTop 5% of 40This company $1.8M Sector average $332.7M
▼
-99.5% below sector average
Key checks
Key Insights
- Chemed Corp.'s interest expense has declined for 3 consecutive years.
- 5-year CAGR of -5.8%, indicating a declining trend.
- In FY2025, interest expense decreased 1.7% year-over-year.
- Ranks #38 out of 40 companies in the Health Care sector.
Company context
Key Data Points
- Altman Z-Score 4.70 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Interest ExpenseValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.8M | -1.7% |
| FY2024 | $1.8M | -42.7% |
| FY2023 | $3.1M | -32.2% |
| FY2022 | $4.6M | +145.4% |
| FY2021 | $1.9M | -20.7% |
| FY2020 | $2.4M | -48.1% |
| FY2019 | $4.5M | -9.1% |
| FY2018 | $5.0M | +16.8% |
| FY2017 | $4.3M | +15.0% |
| FY2016 | $3.7M | +1.9% |
As of FY2025 · SEC 10-K · Updated Mar 29, 2026